pH-Responsive Micelles as Theranostic Agents for Sonodynamic Therapy and MR Imaging of Liver Abscesses

Hong Zhang1,2, Zhichao Cao3, Huanyu Chen1

  • 1The Fourth Affiliated Hospital of Anhui Medical University, Chaohu, Anhui 238000, China.

Insights

This study presents a novel micelle therapy for pyogenic liver abscesses caused by Klebsiella pneumoniae. The pH-responsive micelles deliver antibiotics and sonodynamic agents, improving treatment efficacy and enabling MRI monitoring.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Infectious Diseases

Background:

  • Pyogenic liver abscesses (PLA) caused by Klebsiella pneumoniae (K. pneumoniae) present treatment challenges due to biofilm formation and reduced antibiotic efficacy.
  • The infection microenvironment in PLA can hinder conventional therapeutic approaches.

Purpose of the Study:

  • To develop a pH-responsive micelle system for targeted delivery of levofloxacin (antibiotic) and manganese porphyrin (sonosensitizer).
  • To enable imaging-guided, microenvironment-triggered sonodynamic-antibiotic therapy for K. pneumoniae-associated liver abscesses (KLA).

Main Methods:

  • Co-loading levofloxacin and manganese porphyrin into pH-responsive PC7A micelles.
  • Utilizing ultrasound (US) for sonodynamic therapy (SDT) and MRI for lesion localization and monitoring.
  • Evaluating the system's efficacy in vitro against K. pneumoniae biofilms and in vivo using a murine KLA model.

Main Results:

  • Micelles selectively disassemble in acidic infection niches, releasing therapeutic payloads.
  • MnTPP generates reactive oxygen species upon US exposure, disrupting biofilms and enhancing antibiotic action.
  • In vivo studies demonstrated reduced bacterial burden, decreased inflammation, and promoted hepatic repair in MRI-guided treated mice.

Conclusions:

  • The developed theranostic system integrates microenvironment sensing, controlled release, SDT, and MRI navigation.
  • This approach offers a promising precision strategy for managing deep-seated, drug-resistant K. pneumoniae infections and KLA.
  • The system effectively inhibits biofilm formation and eradicates LEV-resistant K. pneumoniae, suppressing resistance emergence.

Related Concept Videos